News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Luca Arecco: 2nd version of the ESMO Essentials for Clinicians – Breast Cancer
Luca Arecco/X
Nov 30, 2024, 19:29

Luca Arecco: 2nd version of the ESMO Essentials for Clinicians – Breast Cancer

Luca Arecco, Research Fellow at the Jules Bordet Institute, shared a post on X:

“Just released the 2nd version of the The European Society for Medical Oncology (ESMO) Essentials for Clinicians – Breast Cancer.

Honoured to have contributed with a chapter purely focused on Breast cancer in young women. Thanks to Matteo Lambertini for this opportunity and to The European Society for Medical Oncology (ESMO) editorial team for this effort.”

ESMO

Luca Arecco is a Research Fellow at the Jules Bordet Institute and a Medical Oncology Resident at Ospedale Policlinic San Martino. His work centeres on breast cancer research, with a particular emphasis on treating young women with the disease.

More posts featuring Luca Arecco.

Breast Cancer cancer ESMO Jules Bordet Institute Luca Arecco Matteo Lambertini OncoDaily Oncology young women
Special Coverage
Blog
Nov 30, 2024, 19:29
Luca Arecco: 2nd version of the ESMO Essentials for Clinicians - Breast Cancer
Blog
Nov 30, 2024, 19:21
Lung Cancer Cohort Consortium - IARC
Blog
Nov 30, 2024, 19:17
Key takeaways from EMBARK by Bertrand Tombal
Insight
Nov 30, 2024, 19:13
Vivek Subbiah: ADC Target Expression and Interstitial Lung Disease in NSCLC
Blog
Nov 30, 2024, 19:08
6th EORTC Quality of Life in Cancer Clinical Trials Conference
Opinion
Nov 30, 2024, 18:59
Paulo G Bergerot: How exercise nutrition and psychosocial support improve outcomes in Cancer care
Blog
Nov 30, 2024, 18:55
Lisa A. Lacasse: Grateful for the Family, Volunteers, and ACS CAN's Impactful Work
Blog
Nov 30, 2024, 18:50
Francisco J. Esteva: How the MammaPrint test could identify patients who benefit from varying durations of EET
Insight
Nov 30, 2024, 18:43
A Proud Moment for Nigeria - The Dorcas Cancer Foundation
Blog
Nov 30, 2024, 18:34
Razelle Kurzrock: DART hits the target again
Opinion
Nov 30, 2024, 18:30
Young Kwang Chae: Nivolumab/Ipilimumab can be effective in select non-epithelial ovarian cancer
Opinion
Nov 30, 2024, 18:21
Valerie Yang: Are We Over-Treating Some Lymphomas?